WADE JEFFREY L
SEC CIK 1225767 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LXRX | LEXICON PHARMACEUTICALS, INC. | Pres, CFO | 324.2K | $41.9K | — | 8 | 2022-02-28 | 2024-02-28 |
Most active insiders at LXRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Artal Group S.A. | Dir, 10% | $2.00M | — |
| 2 | DEBBANE RAYMOND | Dir | $723.0K | — |
| 3 | Martens Rachel Yap | SVP, Partnerships, Corp Strat | — | — |
| 4 | Gopinathan Suma | SVP, Discovery | — | — |
| 5 | Artal Participations S.a r.l. | Dir, 10% | — | — |
| 6 | Cheung Ivan | Dir | — | — |
| 7 | Exton Michael | CEO, Dir | — | — |
| 8 | Sullivan Diane E. | Dir | — | — |
| 9 | McDermott Wendy | SVP, Human Resources | — | — |
| 10 | Granowitz Craig B | SVP, Chief Medical Off | — | — |
WADE JEFFREY L made no open-market trades at LXRX in the last 12 months.
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-29 | 2024-02-28 | LXRX | LEXICON PHARMACEUTICALS, INC. | WADE JEFFREY L | Pres, CFO | F - Tax | $2.62 | -37.7K | 324.2K | -10% | -$98.8K |
| DM | 2024-02-29 | 2024-02-28 | LXRX | LEXICON PHARMACEUTICALS, INC. | WADE JEFFREY L | Pres, CFO | M - OptEx | — | +97.6K | 361.9K | +37% | — |
| 2023-09-14 | 2023-09-14 | LXRX | LEXICON PHARMACEUTICALS, INC. | WADE JEFFREY L | Pres, CFO | P - Purchase | $1.38 | +10.0K | 264.3K | +4% | +$13.8K | |
| M | 2023-06-20 | 2023-06-20 | LXRX | LEXICON PHARMACEUTICALS, INC. | WADE JEFFREY L | Pres, CFO | P - Purchase | $2.34 | +12.0K | 252.3K | +5% | +$28.1K |
| DM | 2023-03-01 | 2023-02-28 | LXRX | LEXICON PHARMACEUTICALS, INC. | WADE JEFFREY L | Pres, CFO | M - OptEx | — | +78.9K | 272.6K | +41% | — |
| D | 2023-03-01 | 2023-02-28 | LXRX | LEXICON PHARMACEUTICALS, INC. | WADE JEFFREY L | Pres, CFO | F - Tax | $2.17 | -30.3K | 242.3K | -11% | -$65.7K |
| DM | 2022-02-28 | 2022-02-28 | LXRX | LEXICON PHARMACEUTICALS, INC. | WADE JEFFREY L | Pres, CFO | M - OptEx | — | +66.9K | 219.5K | +44% | — |
| D | 2022-02-28 | 2022-02-28 | LXRX | LEXICON PHARMACEUTICALS, INC. | WADE JEFFREY L | Pres, CFO | F - Tax | $2.85 | -25.8K | 193.7K | -12% | -$73.5K |
Purchase Sale Sale after option exercise All abbreviations